- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Northwest Biotherapeutics Inc+ Add to Watchlist
NWBO:US6.4450 USD 0.0050 0.08%
As of 12:47:10 ET on 07/10/2014.
Company Profile for Northwest Biotherapeutics Inc (NWBO)
Northwest Biotherapeutics, Inc., a biotechnology company, discovers, develops, and commercializes immunotherapy products. The Company's products generate and enhance immune system responses to treat cancer. The DCVax product candidate platform creates cancer immunotherapies.
Northwest Biotherapeutics Inc
Key Executives for Northwest Biotherapeutics Inc (NWBO)
|Linda F PowersChairman/President/CEO||Marnix L BoschChief Technology Officer|
|Alton L BoyntonChief Scientific Officer||Anthony E Maida IIISenior VP:Clinical Research|
|Leslie J GoldmanSenior VP:Business Dev|